John R Senior1. 1. Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration (FDA), Department of Health and Human Services, Silver Spring, MD.
Authors: Gerd A Kullak-Ublick; Raul J Andrade; Michael Merz; Peter End; Andreas Benesic; Alexander L Gerbes; Guruprasad P Aithal Journal: Gut Date: 2017-03-23 Impact factor: 23.059